Citadel Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$79M Buy
418,796
+383,553
+1,088% +$80.8M 0.01% 985
2025
Q4
$7M Sell
35,243
-1,020,474
-97% -$206M ﹤0.01% 3761
2025
Q3
$214M Sell
1,055,717
-772,360
-42% -$137M 0.03% 452
2025
Q2
$322M Sell
1,828,077
-38,480
-2% -$5.79M 0.06% 264
2025
Q1
$251M Buy
1,866,557
+1,615,412
+643% +$213M 0.05% 298
2024
Q4
$31.7M Sell
251,145
-1,348,570
-84% -$201M 0.01% 1697
2024
Q3
$266M Sell
1,599,715
-538,314
-25% -$81.4M 0.05% 277
2024
Q2
$284M Buy
2,138,029
+633,965
+42% +$76.3M 0.06% 249
2024
Q1
$158M Buy
1,504,064
+1,402,454
+1,380% +$126M 0.03% 470
2023
Q4
$7.68M Buy
101,610
+54,857
+117% +$3.48M ﹤0.01% 3189
2023
Q3
$3.08M Sell
46,753
-1,253,323
-96% -$93.7M ﹤0.01% 4430
2023
Q2
$106M Buy
1,300,076
+950,213
+272% +$67.6M 0.02% 583
2023
Q1
$20.8M Sell
349,863
-328,354
-48% -$18.3M ﹤0.01% 1881
2022
Q4
$33.1M Buy
678,217
+306,672
+83% +$14.2M 0.01% 1463
2022
Q3
$19.2M Sell
371,545
-1,253,542
-77% -$74.4M ﹤0.01% 1914
2022
Q2
$85.4M Sell
1,625,087
-315,167
-16% -$21.9M 0.02% 659
2022
Q1
$167M Buy
1,940,254
+445,855
+30% +$36.6M 0.03% 419
2021
Q4
$122M Sell
1,494,399
-5,916
-0.4% -$432K 0.02% 553
2021
Q3
$99.7M Sell
1,500,315
-502,470
-25% -$35.6M 0.02% 659
2021
Q2
$134M Buy
2,002,785
+732,788
+58% +$45.4M 0.03% 518
2021
Q1
$66M Buy
1,269,997
+188,908
+17% +$9.55M 0.02% 827
2020
Q4
$43.2M Buy
1,081,089
+394,045
+57% +$12.7M 0.01% 1074
2020
Q3
$16.8M Buy
687,044
+662,590
+2,710% +$16.9M ﹤0.01% 1718
2020
Q2
$443K Sell
24,454
-575,437
-96% -$11.3M ﹤0.01% 7297
2020
Q1
$8.64M Buy
599,891
+424,346
+242% +$12.2M ﹤0.01% 2027
2019
Q4
$6.68M Sell
175,545
-56,439
-24% -$1.69M ﹤0.01% 2709
2019
Q3
$5.13M Sell
231,984
-870,697
-79% -$18.6M ﹤0.01% 3074
2019
Q2
$22.8M Buy
1,102,681
+394,038
+56% +$9.08M 0.01% 1305
2019
Q1
$20.4M Buy
708,643
+468,930
+196% +$11.6M 0.01% 1328
2018
Q4
$4.11M Sell
239,713
-189,930
-44% -$4.6M ﹤0.01% 3061
2018
Q3
$12.2M Buy
429,643
+273,213
+175% +$9.02M 0.01% 1882
2018
Q2
$5.25M Sell
156,430
-129,306
-45% -$4.02M ﹤0.01% 2702
2018
Q1
$6.93M Sell
285,736
-942,844
-77% -$18.8M ﹤0.01% 2090
2017
Q4
$18.6M Buy
1,228,580
+962,610
+362% +$13.5M 0.01% 1198
2017
Q3
$4.37M Sell
265,970
-702,948
-73% -$11.9M ﹤0.01% 2455
2017
Q2
$18.7M Buy
968,918
+175,739
+22% +$3.07M 0.02% 1035
2017
Q1
$14M Sell
793,179
-341,749
-30% -$6.34M 0.01% 1202
2016
Q4
$16.8M Buy
1,134,928
+143,594
+14% +$2.58M 0.02% 978
2016
Q3
$22.5M Buy
991,334
+817,931
+472% +$21.3M 0.02% 803
2016
Q2
$4.79M Sell
173,403
-321,436
-65% -$9.5M 0.01% 1851
2016
Q1
$14.3M Sell
494,839
-133,874
-21% -$3.48M 0.02% 950
2015
Q4
$19.1M Buy
628,713
+295,541
+89% +$9.69M 0.02% 868
2015
Q3
$12.3M Buy
333,172
+79,967
+32% +$4.13M 0.01% 1211
2015
Q2
$14.7M Sell
253,205
-98,086
-28% -$5.01M 0.01% 1219
2015
Q1
$17.4M Buy
351,291
+193,329
+122% +$9.04M 0.02% 1058
2014
Q4
$8M Buy
157,962
+131,245
+491% +$6.86M 0.01% 1572
2014
Q3
$1.59M Sell
26,717
-370,944
-93% -$20.7M ﹤0.01% 3129
2014
Q2
$18.7M Sell
397,661
-232,263
-37% -$10.5M 0.02% 855
2014
Q1
$27M Buy
629,924
+333,644
+113% +$14.7M 0.03% 659
2013
Q4
$12.5M Buy
296,280
+137,708
+87% +$6M 0.02% 1071
2013
Q3
$6.53M Buy
158,572
+120,583
+317% +$5.04M 0.01% 1384
2013
Q2
$1.75M Buy
+37,989
New +$1.7M ﹤0.01% 2629

Other funds holding THC

Citadel Advisors's THC Position: Q1 2026 in Review

Citadel Advisors increased its Tenet Healthcare (THC) stake by 1,088% in Q1 2026, buying an estimated $80.8M and bringing the position to 418,796 shares worth $79M. The position accounts for 0.01% of the portfolio, ranked #985.

Citadel Advisors first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $322M in Q2 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Citadel Advisors held 418,796 shares of Tenet Healthcare worth $79M as of Q1 2026.
  • Citadel Advisors bought 383,553 Tenet Healthcare shares in Q1 2026, an estimated $80.8M.
  • Tenet Healthcare made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #985 holding.
  • Citadel Advisors first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's Tenet Healthcare position peaked at $322M in Q2 2025.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.